tiprankstipranks
Trending News
More News >
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
Advertisement

Olema Pharmaceuticals (OLMA) Stock Statistics & Valuation Metrics

Compare
724 Followers

Total Valuation

Olema Pharmaceuticals has a market cap or net worth of $393.27M. The enterprise value is -$70.36M.
Market Cap$393.27M
Enterprise Value-$70.36M

Share Statistics

Olema Pharmaceuticals has 68,634,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,634,330
Owned by Insiders28.29%
Owned by Institutions<0.01%

Financial Efficiency

Olema Pharmaceuticals’s return on equity (ROE) is -0.32 and return on invested capital (ROIC) is -34.57%.
Return on Equity (ROE)-0.32
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-34.57%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee0.00
Profits Per Employee-1.35M
Employee Count96
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Olema Pharmaceuticals is ―. Olema Pharmaceuticals’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.84
Price to FCF
Price to Operating Cash Flow-3.54
PEG Ratio

Income Statement

In the last 12 months, Olema Pharmaceuticals had revenue of 0.00 and earned -129.47M in profits. Earnings per share was -2.20.
Revenue0.00
Gross Profit-393.00K
Operating Income-142.26M
Pretax Income-129.47M
Net Income-129.47M
EBITDA-129.08M
Earnings Per Share (EPS)-2.20

Cash Flow

In the last 12 months, operating cash flow was -127.16M and capital expenditures 159.00K, giving a free cash flow of -127.00M billion.
Operating Cash Flow-127.16M
Free Cash Flow-127.00M
Free Cash Flow per Share-1.85

Dividends & Yields

Olema Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.80
52-Week Price Change-49.83%
50-Day Moving Average4.88
200-Day Moving Average5.51
Relative Strength Index (RSI)61.96
Average Volume (3m)469.38K

Important Dates

Olema Pharmaceuticals upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date

Financial Position

Olema Pharmaceuticals as a current ratio of 10.50, with Debt / Equity ratio of 0.51%
Current Ratio10.50
Quick Ratio10.50
Debt to Market Cap<0.01
Net Debt to EBITDA1.07
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Olema Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Olema Pharmaceuticals EV to EBITDA ratio is -1.58, with an EV/FCF ratio of -1.96.
EV to Sales0.00
EV to EBITDA-1.58
EV to Free Cash Flow-1.96
EV to Operating Cash Flow-1.96

Balance Sheet

Olema Pharmaceuticals has $361.91M in cash and marketable securities with $1.75M in debt, giving a net cash position of -$360.16M billion.
Cash & Marketable Securities$361.91M
Total Debt$1.75M
Net Cash-$360.16M
Net Cash Per Share-$5.25
Tangible Book Value Per Share$6.95

Margins

Gross margin is -11.26%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-11.26%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Olema Pharmaceuticals is $25.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$25.40
Price Target Upside342.51% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast6.82%

Scores

Smart Score7
AI Score46
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis